Financials data is unavailable for this security.
View more
Year on year Appili Therapeutics Inc grew revenues 147.59% from 334.18k to 827.41k while net income improved from a loss of 9.24m to a smaller loss of 3.78m.
| Gross margin | -- |
|---|---|
| Net profit margin | -461.35% |
| Operating margin | -1,039.87% |
| Return on assets | -173.36% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in CADView more
In 2024, cash reserves at Appili Therapeutics Inc fell by 2.37m. Cash Flow from Financing totalled 122.05k or 14.75% of revenues. In addition the company used 2.46m for operations while cash used for investing totalled 29.06k.
| Cash flow per share | -0.0314 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -0.1021 |
|---|---|
| Tangible book value per share | -0.1021 |
More ▼
Balance sheet in CADView more
| Current ratio | 0.1602 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
